Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 3.9% on Insider Selling

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) shares fell 3.9% during trading on Friday after an insider sold shares in the company. The stock traded as low as $8.35 and last traded at $8.43. 724,610 shares were traded during mid-day trading, a decline of 49% from the average session volume of 1,433,050 shares. The stock […]

Related Keywords

Tina Marriott Larson ,Christopher Gibson ,Institutional Trading Of Recursion Pharmaceuticals ,Needham Company ,News Ratings For Recursion Pharmaceuticals Daily ,Artal Group ,Recursion Pharmaceuticals ,Nasdaq ,Cypress Point Wealth Management ,Sg Americas Securities ,Recursion Pharmaceuticals Company Profile ,Crown Advisors Management Inc ,Recursion Pharmaceuticals Stock Down ,Morgan Stanley ,Recursion Pharmaceuticals Inc ,Securities Exchange Commission ,Get Rating ,Marriott Larson ,Exchange Commission ,Pharmaceuticals Stock Down ,Point Wealth Management ,Advisors Management ,Recursion Pharmaceuticals Daily ,Nasdaq Rxrx ,Rxrx ,Medical ,Stocks ,Technicals ,